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INTRODUCTION
Phencyclidine  (PCP,  “angel  dust”)  is  an  infamous 
hallucinogenic sought for its ability to induce the illusion of 
euphoria, omnipotence, superhuman strength, and social and 
sexual  prowess.    The  acronym  PCP  stems  from  its  organic 
name -(-phenylcyclohexyl) piperidine, which alludes to its 
relatively  simple  production  from  the  arylcyclohexylamine 
piperidine., 2  
More than 60 designer analogs more toxic than PCP, but 
able to escape clinical detection, were common before the sale 
of piperidine and its derivatives became illegal in the United 
States in 1978. Ketamine is the only one authorized for medical 
use, and it was often stolen from veterinary offices for its PCP-
like effects.3
Like ketamine, PCP was formerly used as a preinduction 
anesthetic and animal tranquilizer, hence it has street eponyms 
such as “horse tranquilizer,” hog,” and “elephant”.4, 5 It was 
prized for its ability to provide anesthesia and analgesia without 
triggering cardiorespiratory depression, but was soon recalled 
when patients experienced psychosis, agitation, and dysphoria 
post-operatively.6
PCP has re-emerged as a drug of abuse in this decade since 
its decline after the 1980s. In 1979, 12.8% of twelfth graders 
had used PCP, whereas in 997 only 3.9% had used this drug. 
However, phencyclidine continues to be found in PCP-laced 
marijuana cigarettes (“whacko tobacco”), and has been detected 
in up to 24% of street marijuana samples. Regrettably, exposure 
to the smoke and butts of these cigarettes has resulted in many 
cases of occult pediatric PCP intoxication.3
Pharmacology
PCP is available as a white crystalline powder (“angel dust”), 
tablet (“PeaCe Pill”), crystals, and liquid (“whack”); with these 
varied forms, it can be snorted, smoked, ingested or injected 
intravenously or subcutaneously.1, 7, 8  
A typical PCP-laced marijuana cigarette contains  to 0mg 
of the drug. The average tablet varies in weight from  to 6 mg.3, 
9 Only 0.25 mg of IV solution is required to produce sedation, 
compared to 0mg required via ingestion or inhalation.0
Inhalation  accounts  for  70%  of  usage,  however,  because 
onset of action occurs in 2-5 minutes, without the complications 
of injection. Effects may take 5 to 60 minutes when ingested 
orally.3, 6, , 2 Phencyclidine is a weak base that is lipid, water, 
and  alcohol  soluble,  giving  it  an  extraordinary  volume  of 
distribution of 6.2 L/kg.2 Thus, the relationship between dose, 
serum level, and effects varies depending upon body habitus, 
nutritional state, and alcohol coingestion.3, 3, 4 
Walberg et al. did not find any direct relationship of serum 
concentration of PCP and the clinical pattern of intoxication in a 
case series of 26 patients with “pure” PCP intoxication.5 This 
lack of correlation of plasma concentration and clinical effects 
of PCP is poorly understood. Additionally, no relevant data or 
literature could be found to correlate PCP concentrations in the 
cerebrospinal fluid (CSF) with the clinical effects of the drug.     
In  animal  experiments  PCP-binding  antibodies  actually 
increased  serum  concentrations  of  PCP,  indicating  that  they 
simply alter its distribution.6 PCP levels are highest in adipose 
tissue, and because of its slow, uneven release from lipid stores, 
the half-life of PCP is believed to be three days.3, 3 Due to the 
brain’s high lipid content and ion trapping, cerebral levels of 
PCP may be nine times serum levels, allowing its CNS effects 
to last from seven hours to as long as seven days in chronic 
users.7
Regardless  of  the  method  of  administration,  significant 
amounts of the weakly basic PCP are actively secreted into 
the acid milieu of the stomach, accumulating to levels up to 
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50 times higher than serum levels, where it is then reabsorbed 
in the small intestine. Fortunately, however, 90% of the drug is 
metabolized on first pass via oxidative hydroxylation in the liver. 
These metabolites are then glucuronidated for renal excretion 
with the 9% of active drug that is excreted directly.2
 Phencyclidine  is  believed  to  have  several  sites  of  action 
in the central nervous system, all of which act synergistically 
to result in anesthesia and analgesia. It has greatest affinity for 
the NMDA (N-methyl-D-aspartate) receptor complexes in the 
hippocampus,  neocortex,  basal  ganglia,  and  limbic  system.18 
There  are  three  major  neuronal  interactions  of  PCP,  which 
occur at serum concentrations compatible with life up to 1 μM/
mL. PCP has a decreasing affinity to NMDA receptors, to the 
neuronal norepinephrine (NE), dopamine (DA), and serotonin 
(5-HT) reuptake system and to the σ opioid receptors.6, 18 At 
moderate  doses  of    to  5mg  orally,  PCP  inhibits  dopamine, 
norepinephrine, and serotonin reuptake, and increases dopamine 
and  norepinephrine  production  by  stimulating  tyrosine 
hydroxylase, resulting in dopaminergic and sympathomimetic 
effects.9, 20
  The  NMDA-Phencyclidine  complex  includes  a  calcium 
channel  stimulated  by  excitatory  neurotransmitters  such  as 
glutamate, glycine, and aspartate, but inhibited by phencyclidine 
at  a  PCP-specific  binding  site.9  Paradoxically,  PCP  also 
causes CNS excitation via glutamate release at the presynaptic 
metabotropic receptors. Metabotropic receptors are G-protein 
rather than ion-gated channels.2 (Table )
CLINICAL MANIFESTATIONS
 Over 50% of adult patients present with the classic toxidrome 
of PCP intoxication: violent behavior, nystagmus, tachycardia, 
hypertension, anesthesia, and analgesia., 7, 22, 23
 The clinical picture may wax and wane between extreme 
agitation  and  sedation,  because  PCP  can  produce  CNS 
stimulation and depression through its different clinical effects 
in  the  CNS.  With  increasing  concentrations,  the  drug  binds 
to NMDA receptors, acts as a monoamine reuptake inhibitor, 
stimulates σ-opioid receptors, as well as nicotinic, muscarinic 
and GABA receptors.6, 18 Sedation and loss of inhibition tend 
to occur with ingestions of 1 to 5 mg, with the CNS findings of 
slurred speech, violent behavior and blank staring, horizontal, 
vertical,  or  rotatory  nystagmus,  ataxia,  hyperthermia,  and 
seizures at these doses (Table 2).3, 6, 9, 4, 23
 PCP’s most unusual feature is that doses of 5 to 0 mg orally 
may induce acute schizophrenia, including agitation, psychosis, 
audiovisual hallucinations, paranoid delusions, and catatonia. 
Doses greater than 0 mg usually result in coma.3, , 2 In animal 
experimental studies PCP is used to investigate the neurochemical 
basis  of  schizophrenia.  Low  doses  of  phencyclidine  have 
produced patterns of metabolic and neurochemical changes in 
rodent  brains  that  resemble  those  in  brains  of  schizophrenic 
patients.24 A  typical  PCP-induced  coma  is  manifested  as  an 
unresponsive patient whose eyes remain open., 0 
 The very characteristics that made PCP ideal for anesthesia 
at moderate doses – absence of cardiorespiratory depression or 
muscle hypotonia – make it dangerous at higher recreational 
doses. It produces sympathomimetic signs such as hypertension, 
tachycardia, and diaphoresis similar to cocaine, and cholinergic 
signs like bronchospasm, salivation, urinary retention, flushing, 
and miosis, similar to opiates. The most common of these are 
tachycardia and hypertension., 25
 PCP has also been shown to be a direct cardiac irritant, and 
may induce arrhythmias and vasospasm. In addition, muscle tone 
becomes exaggerated, and patients may exhibit hyperreflexia, 
and myoclonic, dystonic or choreoathetoid movements such as 
opisthotonos and torticollis.9  Complications of this hypertonic 
muscle  activity  include  hyperthermia  and  rhabdomyolysis.9, 
4,7,26
 Respiratory depression requiring intubation is uncommon 
in  PCP  intoxication; however,  patients may exhibit irregular 
breathing,  with  episodes  of  both  apnea  and  tachypnea.9, 
22  Furthermore,  pharyngeal  and  laryngeal  reflexes  become 
hyperactive, and sympathomimetic effects create bronchorrhea, 
Table 1. Pharmacology of Phencyclidine (PCP) in the 
               central nervous system
________________________________________________ 
•	 PCP has contrary actions on the glutamate 
transmission, explaining its different effects
  -  Inhibits the ion flux at the NMDA glutamate 
       receptor
  -  Increases glutamate transmission at non-NMDA  
       receptors 
      (G-protein mediated response)
•	 Inhibits the GABAergic output
•	 Decreases DA and NE uptake
•	 Increases the DA and NE levels by stimulating the 
enzyme tyrosine hydroxylase
GABA:    γ - aminobutyric acid
NMDA:   N-methyl D-aspartate
DA:         dopamine
NA:         norepinephrine
 Modified after Williams and Keyes (Williams, 2001 #16) 
 and Brust (Brust, 1999 #6)
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which exacerbate the risk of airway obstruction in an already 
obtunded patient.9, 22, 27
Non-traumatic  causes  of  death  include  cardiopulmonary 
arrest,  intracranial  hemorrhage  in  hypertension,  and 
hyperkalemia secondary to rhabdomyolysis.9, 22  Most deaths 
in  PCP-intoxicated  patients,  however,  result  from  patients’ 
violent behavior, rather than direct effects of the drug.1, 14, 23, 28   
The bizarre and violent behavior generated by PCP, combined 
with its analgesic effects, may result in significant self-inflicted 
trauma. Patients have walked into traffic, jumped from buildings, 
and even enucleated their own eye.29
Patients  recovering  from  PCP  exposure  may  undergo  an 
emergence  reaction  as  the  drug  is  eliminated,  consisting  of 
psychosis, bizarre behavior, or depression that may last from 
days to weeks.28 Prolonged psychosis is more commonly seen 
in chronic abusers, and is a poor prognostic sign, as the patient 
may go on to develop true schizophrenia. Depression, anxiety, 
irritability,  restlessness,  anergia,  and  disturbances  of  thought 
and sleep have been described in as little as a day of abstinence 
in chronic abusers. Oculomotor hyperactivity, tremor, diarrhea, 
and piloerection were reported within 8 hours of abstinence in 
monkeys chronically administered PCP.30
Effects of PCP in Children
Ikonomidou et al. point out that during the period of rapid 
growth  of  the  mammalian  brain,  neuronal  apoptosis  can  be 
triggered by the transient blockade of the glutamate.3 Olney’s 
animal experimental findings support the induction of neuronal 
cell  death  by  NMDA  antagonists  like  PCP.  Different  brain 
regions display different age-dependent vulnerabilities to NMDA 
receptor-blocking drugs, leading to different patterns of neuronal 
loss depending on the time of exposure. 32 In humans, the brain 
growth spurt period starts in the sixth month of gestation and 
extends to the third year of life.3 
Thus, young children are very sensitive to PCP, and develop 
serious  neurologic  signs  with  minimal  exposure.  They  can 
become  intoxicated  from  passive  inhalation  of  secondhand 
smoke,  or  by  ingesting  the  butts  of  PCP-impregnated 
cigarettes.3 These signs may present as listlessness, irritability, 
and poor feeding in newborns, and should immediately raise 
suspicion for intoxication.3 Different forms of choreoathetosis 
were seen in half of the cases. Hypertension and seizures are 
the next most common signs in infants, seen 30 and 20% of 
the time, respectively.3 Blood pressure elevations are common 
during the first six hours of intoxication, but usually resolve 
spontaneously.
Seizures, apnea, and respiratory depression are documented 
more frequently in children than adults; however, they rarely 
require intubation. Violent behavior is less common in children, 
which may explain the lack of mortality reported in children.3, 
33  Mild  intoxication  in  children  may  present  as  lethargy 
alternating  with  agitation,  a  dull  trance-like  stare,  horizontal 
or vertical nystagmus, miosis, truncal ataxia, choreoathetosis, 
hypersalivation, and mild hypertension, and may last from 2 
hours to over three days.9, 0, 33 Severe intoxication, including 
unresponsiveness with an open-eyed stare and short intermittent 
generalized seizures, may last up to six days.33
Diagnosis
Phencyclidine  intoxication  is  a  diagnosis  that  must  be 
suspected clinically so that the appropriate tests are ordered for 
confirmation. The differential diagnosis of the clinical picture 
created  by  PCP  includes  other  intoxications,  schizophrenia, 
intracranial pathology, hypoxia, hypoglycemia, hyponatremia, 
sepsis, meningitis and encephalitis, thyroid storm, and neuroleptic 
Table 2.  Neuropsychiatric and clinical effects of PCP 
                at different doses
________________________________________________
Estimated ingested amount   Clinical effects
2-5 mg (Stage I)    Unpredictable, drunk, 
       euphoric, disoriented,
combativeness, rage 
   obscenity. 
   Alternating periods of 
   lethargy and fearful 
   agitation: waxing and 
   waning. 
Decreased but intact pain 
perception, midpoint 
pupils, nystagmus, ataxia 
differentiates PCP from 
stimulants. 
5-25 mg (Stage II)     Stupor, mild coma, intact
response to deep pain, 
muscle contractions, 
bizarre postures.
More than 25 mg (Stage III)  Comatose with no
         response to deep pain, 
        hyperthermia,
 convulsions, death.
Modified after Milhorn HT (Milhorn, 1991 #7) and 
Williams and Keyes (Williams, 2001 #16)  
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malignant syndrome. PCP intoxication shares many features with 
overdoses  of  cocaine,  amphetamines,  anticholinergic  agents, 
hallucinogens, and withdrawal from benzodiazepines. Therefore, 
a  qualitative  urine  toxicologic  screen  has  become  mandatory 
standard of care for any patient, infant or adult, with altered mental 
status of unknown etiology.3 Although earlier literature describes 
three dose-related stages of PCP intoxication, quantitative PCP 
levels do not correlate well with clinical findings and thus should 
not guide clinical management., 6, 3, 20, 22
 The  simplest  way  to  confirm  suspected  PCP  intoxication 
is via qualitative chromatographic or immunologic urine drug 
screen, since 9% of the active drug is excreted directly by the 
kidneys. The urine is usually positive for 2-4 days after PCP 
use, but after chronic exposure the test results can be positive for 
over a week.34
 Several  drugs  like  diphenhydramine,  dextromethorphan, 
and venlafaxine and its derivatives may cause a urine specimen 
to test positive for PCP if tests other than gas chromatography/
mass  spectrophotometry  (GS/MS)  are  used,  such  as  the 
fluorescence polarization immunoassay or high pressure liquid 
chromatography.35, 36
 Bond et al. report a case of a 3-year-old girl who presented 
with  a  massive  venlafaxine  overdose  and  a  false  positive 
fluorescent-polarized  immunoassay  for  phencyclidine  in  the 
urine. The GS/MS, however, identified venlafaxine as the only 
substance present in the serum.37 Conversely, urine drug screens 
may be negative in the face of alkaline urine, since phencyclidine 
is a weak base. In this situation, saliva or gastric contents can be 
analyzed for PCP.33
 Because  PCP-induced  seizures,  myoclonic  activity,  and 
trauma may result in rhabdomyolysis, serum potassium, blood 
urea  nitrogen,  creatinine,  and  creatine  phosphokinase  (CPK) 
should be ordered any time it is suspected. Serum CPK is the 
preferred  screening  method  for  rhabdomyolysis,  because  the 
presence of urinary myoglobin may be transient.22, 26 Capillary 
and serum blood glucose levels are also recommended since PCP 
has been associated with hypoglycemia in 20% of patients.9
Management
The  management  of  PCP  intoxication  begins  just  as  any 
other intoxication would. First, the patient’s airway, breathing, 
circulation,  thermoregulation,  and  neurologic  status  must  be 
stabilized.  The  patient  should  then  be  restrained  and  sedated 
if necessary to prevent self-inflicted injury, which is the most 
common cause of morbidity and mortality in these patients.6, 4, 23, 
29, 38  
     Chemical restraints are preferred over physical restraints, which 
may exacerbate the risk of rhabdomyolyis.9, 22, 26 Benzodiazepines 
are recommended in patients without psychosis, as antipsychotics 
can  amplify  PCP-induced  hyperthermia,  dystonic  as  well  as 
anticholinergic  reactions,  and  lower  the  seizure  threshold.3,  38 
However, haloperidol has been described as a useful treatment 
for PCP-induced psychosis provided the patient is not hyperthermic. 
The risks of lengthening of the QT interval, torsade de pointes and 
adverse  neurologic  effects  limit  the  use  of  haloperidol  in  PCP-
intoxicated patients. Due to their more favorable side effect profile, 
atypical antipsychotics like olanzipine or ziprazidone would be a 
better choice than haloperidol when treating PCP-induced agitation 
and psychosis. Diphenhydramine 50mg IV or mg/kg can be used 
to treat PCP-induced (or haloperidol-induced) dystonic symptoms, 
but should be administered after a urine sample is obtained for 
toxicologic screening, since it may cause the specimen to test falsely 
positive for PCP.3 Diphenhydramine may also cause tachycardia 
and problems with thermoregulation via its anticholinergic effects, 
so the benefits of its use should be weighed against its potential side 
effects. Patients should then be closely observed in a dark and quiet 
environment, with minimal auditory and tactile stimuli so as not to 
provoke violent outbursts.3
As with all intoxications, a blood glucose measurement should 
be obtained, and 00 mg thiamine and dextrose 50% should be 
administered if the blood sugar is abnormally low. Naloxone, to 
treat potentially coingested opiates, is not necessary in patients with 
adequate respiration.  
   Gastric    lavage is controversial, and should only be used after 
consultation  with  a  toxicologist. Activated  charcoal  at  standard 
dose of  g/kg is strongly recommended in suspected PCP ingestion 
to prevent further absorption of the drug during its entero-hepatic 
recirculation, and serial doses may be necessary to prevent later 
redistribution from lipid stores.34, 39 An intoxicated patient should 
always be assessed first for deterioration of mental status, aspiration 
potential and possible airway complications before administering 
charcoal.  
   Patients must be on continuous cardiac monitoring because of the 
frequency  and  severity  of  cardiac  symptoms.9,  33  Diastolic  hypertension 
>5 mmHg may be transient, or fall after sedation, eliminating the 
need for further treatment.  
  There are case reports of intracerebral hemorrhage secondary to 
hypertension.40 Additionally, Welch et al. describes several cases 
of  intracerebral  hemorrhage  in  infants  that  were  not  visualized 
on CT and have been diagnosed by lumbar puncture, suggesting 
that physicians should have a low threshold for performing this 
procedure in the face of hypertension and neurologic abnormalities, 
especially in children.0 
   In the past, PCP elimination was thought to be enhanced by urinary 
acidification via ammonium chloride or ascorbic acid; however, 
this  is  no  longer  recommended  because  acidic  urine  increases 
the risk of acute tubular necrosis secondary to myoglobinuria in 
rhabdomyolysis.22, 26 Furthermore, only 9% of PCP is excreted in 
the urine., 2 Urinary acidification will not affect the 91% that is 
metabolized by the liver, and thus will not increase overall removal of 
the drug. Hemodialysis is also ineffective because it simply removes 
the drug from the serum, clearing the path for redistribution from 
lipid stores. Hemodialysis is, however, a treatment option for renal 
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be far more dangerous than PCP intoxication; therefore patients 
with rhabdomyolysis should be aggressively treated with fluids, 
sodium bicarbonate, mannitol and furosemide. 
Status epilepticus should be treated with airway protection 
and IV benzodiazepines or phenobarbital. The patient should 
not be paralyzed after rapid sequence intubation (RSI) because it 
is then virtually impossible to monitor whether seizures are still 
ongoing, short of continuous EEG monitoring.38 Hyperthermia 
greater than 40°C may be the combined result of PCP-induced 
myotonic  activity,  seizures,  and  rhabdomyolysis,  and  should 
be  aggressively  treated  with  mechanical  cooling  measures. 
Benzodiazepines are a useful adjunct to prevent shivering and 
provide sedation. 
Disposition
Patients with rhabdomyolysis, hyperthermia, altered mental 
status,  seizures,  significant  injuries,  or  pediatric  age  require 
hospitalization. Children require continuous monitoring to note 
fluctuations  in  consciousness,  cardiorespiratory  stability,  and 
for suction of excess oral secretions. 
Mildly  intoxicated  patients  should  return  to  normal 
functioning four to eight hours after ingestion, whereas larger 
ingestions may require weeks. Infants have been reported to 
need from 48 hours to four days to recover.3 Delayed recovery 
should be closely monitored in the ICU, because these patients 
may  experience  depression,  anxiety,  and  severe  psychiatric 
disturbances in the post-high period.
Finally, it is important to investigate the source of intoxication, 
whether it be in an adult who is unknowingly inhaling PCP-
laced marijuana cigarettes, or more tragically, a child who is 
unwillingly exposed to secondhand smoke.0
SUMMARY
In conclusion, phencyclidine is a unique, paradoxical drug 
that produces central nervous system depression and peripheral 
and central nervous system stimulation. Because of its relative 
safety and euphoric effects, we are beginning to see a recurrence 
of PCP’s street popularity. Hallmark clinical findings of PCP 
intoxication are nystagmus, hypertension and a mental status, 
which is often described as dissociative anesthesia. In higher 
doses  patients  become  unconscious  and  can  succumb  to 
pulmonary  aspiration  and  cardiovascular  collapse. The  most 
disturbing behavioral effects of PCP are violent, aggressive and 
bizarre behavior with self-mutilation tendencies. 
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